Industry and Company News
The Doctors Company Announces Record Tribute Plan Milestone: Over $200 Million Distributed to Members
The Doctors Company has now distributed more than $200 million in Tribute® Plan awards to over 15,000 members. Founded in 2007, the Tribute Plan is an unrivaled financial benefit that rewards retiring healthcare professionals for their loyalty and dedication to superior patient care. It is the largest such benefit in the industry, with the highest individual award to date exceeding $260,000.
“The Tribute Plan is a powerful reflection of our mission to advance, protect, and reward the practice of good medicine,” said Richard E. Anderson, MD, FACP, Chairman and CEO of The Doctors Company and TDC Group. “It represents our long-term commitment to our members—and to the practice of medicine itself.”
Backed by our financial strength of $7.8 billion in assets and $3.1 billion in member surplus, the Tribute Plan has received continuous annual funding since its launch. Unlike many liability insurers that have paused or ended similar programs, The Doctors Company continues to fund Tribute from our own capital—not from premiums. Tribute payments are in addition to our ongoing dividend program.
Fitch Ratings Affirms ‘A’ Ratings, ‘Stable’ Outlook for The Doctors Company
Fitch Ratings has affirmed its “A” (Strong) Insurer Financial Strength ratings for The Doctors Company. The outlook of these ratings is “Stable.”
Fitch noted that the ratings are based on a very strong capital position, stable underwriting, and sufficient loss reserve levels. Fitch stated that our announcement of a definitive agreement to acquire ProAssurance Corporation is consistent with our operating strategy and core business, strengthening our scale and position in medical professional liability insurance.
The Doctors Company Named in 2025 Ward’s 50
The Doctors Company has been named in the 2025 Ward’s 50 top-performing insurers. We were chosen out of nearly 3,000 property-casualty insurance companies, and this honor recognizes our outstanding financial results in the areas of safety, consistency, and performance over a five-year period (2020–2024).
Federal Trade Commission Grants Approval for The Doctors Company’s Planned Acquisition of ProAssurance
The Doctors Company and ProAssurance Corporation have announced that on July 2, 2025, the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) with respect to the pending acquisition of ProAssurance by The Doctors Company.
The termination of the waiting period under the HSR Act satisfies one of the conditions for the closing of the pending acquisition, which is expected to be completed in the first half of 2026, but which remains subject to other customary closing conditions, including receipt of the remaining regulatory approvals. The Doctors Company and ProAssurance will continue to operate independently until closing occurs.
Survey Reveals Only 12 Percent of Physicians Likely to Recommend Medicine as a Career, Citing Misinformation and Lack of Trust
A new physician survey by The Doctors Company reveals only 12 percent of physicians would recommend medicine as a career to others. The top reason: 64 percent of physicians named medical misinformation on social media as the most challenging part of practicing medicine. Learn strategies to address this top issue and support engaged patients.
The Doctors Company Appoints Three New Healthcare Leaders to Board of Governors
The Doctors Company is pleased to announce the appointment of John M. Haupert, FACHE; Henna A. Karna, PhD; and Ami Parekh, MD, JD, to our Board of Governors.
The Doctors Company Board of Governors comprises an accomplished, distinguished group of professionals who are passionate about advancing, protecting, and rewarding the practice of good medicine. The Board includes physicians, healthcare leaders, and distinguished executives—representing many of the nation’s leading medical centers, property and casualty insurers, and financial advisors.
Inflation Added $4 Billion to Medical Malpractice Losses, The Doctors Company Study Finds
The Doctors Company's new research indicates that inflation—both economic and social—has added an estimated $4 billion in insured losses and expenses to the medical malpractice insurance market over the past decade.
The study, Nuclear Verdicts and Rising Costs: How Inflation Is Impacting Medical Malpractice Claims, found that the $4 billion in losses from inflation represent 11 percent of booked losses for the decade ending in 2024. This was a significant increase from the $2.4 to $3.5 billion (8 to 11 percent) that was found in our 2023 research report that addressed the impact of social inflation on medical malpractice claims for the decade ending in 2021. The latest research confirms that inflation is not only persistent—it’s accelerating.
The Doctors Company Named Finalist for (Re)Insurer of the Year
The Doctors Company has been named a finalist for Insurer of the Year, a 2025 Insurance Insider US Honor. The Insurance Insider US Honors celebrate and reflect on the outstanding contributions and achievements of the (re)insurance industry.
We join an impressive list of organizations nominated in various categories. The winners will be announced at the US Honors Awards on Thursday, September 25, 2025.
Keep an Eye on Your Mailbox: Make Your Voice Heard
Our Member Experience Survey is a vital tool that allows us to listen to our members and gather insights to make improvements across the company. We greatly appreciate all our members who have already responded to our ongoing digital Member Experience Survey. If you have not yet responded and would prefer to take the survey on paper, keep an eye on your mailbox—a paper version of the survey should be arriving in the next few weeks. Your feedback is invaluable as we work to provide all our members with the best imaginable service.
The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.
The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.
The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.
The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.
